18775702.xml

<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE collection SYSTEM "BioC.dtd"><collection><source>PMC</source><date>20140719</date><key>pmc.key</key><document><id>2577129</id><passage><infon key="article-id_doi">10.1016/j.febslet.2008.08.031</infon><infon key="article-id_pmc">2577129</infon><infon key="article-id_pmid">18775702</infon><infon key="article-id_publisher-id">FEBS32792</infon><infon key="fpage">3275</infon><infon key="issue">23-24</infon><infon key="kwd">ASFV, African swine fever virus GST, glutathione S-transferase FU, 5-fluorouridine hpi, hours post infection African swine fever virus p30 Ribonucleoproteins Virus-cell interaction</infon><infon key="license">This document may be redistributed and reused, subject to certain conditions.</infon><infon key="lpage">3280</infon><infon key="name_0">surname:Hernaez;given-names:Bruno</infon><infon key="name_1">surname:Escribano;given-names:Jose M.</infon><infon key="name_2">surname:Alonso;given-names:Covadonga</infon><infon key="title">Abbreviations Keywords</infon><infon key="type">front</infon><infon key="volume">582</infon><infon key="year">2008</infon><offset>0</offset><text>African swine fever virus protein p30 interaction with heterogeneous nuclear ribonucleoprotein K (hnRNP-K) during infection</text></passage><passage><infon key="type">abstract</infon><offset>124</offset><text>Heterogeneous nuclear ribonucleoprotein K (hnRNP-K) was identified as interacting cellular protein with the abundant immediate early protein p30 from African swine fever virus (ASFV) in a macrophage cDNA library screening. The interacting regions of hnRNP-K with p30 were established within residues 35–197, which represent KH1 and KH2 domains responsible for RNA binding. Colocalization of hnRNP-K and p30 was observed mainly in the nucleus, but not in the cytoplasm of infected cells and infection modified hnRNP-K subcellular distribution and decreased the incorporation of 5-fluorouridine into nascent RNA. Since similar effects were observed in cells transiently expressing p30, this interaction provides new insights into p30 function and could represent a possible additional mechanism by which ASFV downregulates host cell mRNA translation.</text></passage><passage><infon key="type">abstract_title_1</infon><offset>975</offset><text>Structured summary</text></passage><passage><infon key="type">abstract</infon><offset>994</offset><text>MINT-6742660:</text></passage><passage><infon key="type">abstract</infon><offset>1008</offset><text>hnRNP-K (uniprotkb:P61978) physically interacts (MI:0218)</text></passage><passage><infon key="type">abstract</infon><offset>1066</offset><text>with p30 (uniprotkb:Q8V1E7) by pull down (MI:0096)</text></passage><passage><infon key="type">abstract</infon><offset>1117</offset><text>MINT-6742673, MINT-6742696, MINT-6742729:</text></passage><passage><infon key="type">abstract</infon><offset>1159</offset><text>hnRNP-K (uniprotkb:P61978) physically interacts (MI:0218)</text></passage><passage><infon key="type">abstract</infon><offset>1217</offset><text>with p30 (uniprotkb:Q8V1E7) by two hybrid (MI:0018)</text></passage><passage><infon key="type">abstract</infon><offset>1269</offset><text>MINT-6742711:</text></passage><passage><infon key="type">abstract</infon><offset>1283</offset><text>p30 (uniprotkb:Q8V1E7) and hnRNP-K (uniprotkb:P61978) colocalize (MI:0403) by fluorescence microscopy (MI:0416)</text></passage><passage><infon key="type">abstract</infon><offset>1395</offset></passage><passage><infon key="type">title_1</infon><offset>1396</offset><text>Introduction</text></passage><passage><infon key="type">paragraph</infon><offset>1409</offset><text>African swine fever virus (ASFV), the only member of the Asfarviridae family, is a large, cytoplasmic, double-stranded DNA virus that is responsible of a haemorrhagic and frequently fatal disease of swine [1]. The viral genome comprises more than 150 open reading frames and expression is regulated in a temporal fashion. So, viral genes are classified as early or late depending on their requirement for viral DNA synthesis [2]. Little is known about the regulatory functions of ASFV proteins during infection and early virus proteins are important candidates to play critical roles in the modification of cellular metabolism to take advantage of host cell functions.</text></passage><passage><infon key="type">paragraph</infon><offset>2078</offset><text>ASFV open reading frame CP204L encodes a 30 kDa protein named p30 or p32 [3,4] which represents the most abundantly expressed viral protein early in infection. p30 exhibits a predominantly cytoplasmic location within infected cells and results phosphorylated in serine residues at the N-terminal [4] before its final incorporation to the viral particle. p30 is also one of the most antigenic ASFV proteins [5], eliciting virus neutralizing antibodies in infected animals [6–8]. Previous studies have demonstrated a role for p30 in first stages of infection, since antibodies against p30 are able to inhibit virus internalization into the host cell [6]. Nevertheless, the regulatory function of p30 upon infection remains largely unknown.</text></passage><passage><infon key="type">paragraph</infon><offset>2819</offset><text>To explore the potential targets of p30 during infection, we have used the yeast two-hybrid system to screen a porcine macrophage (the natural viral host cell) cDNA library for cellular proteins that may interact with p30. We have identified heterogeneous nuclear ribonucleoprotein K (hnRNP-K) as the first cellular ligand of p30.</text><annotation id="0"><infon key="type">ExperimentalMethod</infon><infon key="PSIMI">0018</infon><location offset="2819" length="330"/><text>To explore the potential targets of p30 during infection, we have used the yeast two-hybrid system to screen a porcine macrophage (the natural viral host cell) cDNA library for cellular proteins that may interact with p30. We have identified heterogeneous nuclear ribonucleoprotein K (hnRNP-K) as the first cellular ligand of p30.</text></annotation></passage><passage><infon key="type">paragraph</infon><offset>3150</offset><text>hnRNP-K is a multifunctional protein since it has been described to interact with diverse molecules of cellular [9,10], and viral origin [11–14], being involved in a variety of cellular functions such as regulation of transcription and translation [15], RNA splicing, mRNA stability and transport of pre-mRNA out of nucleus to cytoplasm. It has been demonstrated to interact with different molecules involved in signal transduction such as Src, Fyn and Lyn [16]. Recently, a number of new hnRNP-K partners have been identified by using a proteomic approach [17] and new roles have been suggested for this protein. ASFV p30 was found to interact directly with host hnRNP-K during ASFV infection and we have mapped the interacting regions of both proteins. p30 modifies hnRNP-K subcellular distribution and could contribute to modulate hnRNP-K functions related to processing and export of mRNAs during ASFV infection.</text></passage><passage><infon key="type">title_1</infon><offset>4069</offset><text>Materials and methods</text></passage><passage><infon key="type">title_2</infon><offset>4091</offset><text>Plasmids</text></passage><passage><infon key="type">paragraph</infon><offset>4100</offset><text>For the yeast two-hybrid assay, plasmids pGBT9 and pACT2 (BD Sciences) were used as sources of the GAL4 DNA-binding domain (BD) and transcriptional activation domain (AD), respectively. To generate pGBT9-p30, the complete p30 coding sequence was directly amplified from ASFV genome of E70 isolate and inserted in EcoRI and BamHI sites in pGBT9. Unrelated ASFV protein p54 was used as negative control and cloned in pGBT9, as previously published [18]. A cDNA library from porcine macrophage, cloned in XhoI site in pACT2, was kindly provided by Linda Dixon [19]. p30 and hnRNP-K different mutant truncations used for mapping the regions involved in the interaction were generated by PCR from pGBT9-p30 and pGEX-RNP-K, respectively. The fragments generated were inserted in frame with AD or BD in pGBT9 or pACT2. pACT2-K, containing complete hnRNP-K coding sequence fused to AD, was derived from pGEX-RNP-K. pCMV-p30 was also derived from pGBT9-p30 and used in transfection experiments. For the glutathione S-transferase (GST) pull-down experiments, plasmids pGEX-RNP-K (kindly provided by Dr. Levens) and pGEX-4T (GE Healthcare) were used to express GST-hnRNP-K fusion protein or GST alone in Escherichia coli.</text><annotation id="1"><infon key="type">ExperimentalMethod</infon><infon key="PSIMI">0018</infon><location offset="4100" length="185"/><text>For the yeast two-hybrid assay, plasmids pGBT9 and pACT2 (BD Sciences) were used as sources of the GAL4 DNA-binding domain (BD) and transcriptional activation domain (AD), respectively.</text></annotation><annotation id="2"><infon key="type">ExperimentalMethod</infon><infon key="PSIMI">0096</infon><location offset="5086" length="224"/><text>For the glutathione S-transferase (GST) pull-down experiments, plasmids pGEX-RNP-K (kindly provided by Dr. Levens) and pGEX-4T (GE Healthcare) were used to express GST-hnRNP-K fusion protein or GST alone in Escherichia coli.</text></annotation></passage><passage><infon key="type">title_2</infon><offset>5311</offset><text>Yeast two-hybrid</text></passage><passage><infon key="type">paragraph</infon><offset>5328</offset><text>pGBT9-p30 and unrelated control protein pGBT9-p54 were independently used as baits to screen a pACT2 cDNA library from pig macrophages in Saccharomyces cerevisiae reporter strain Y190 as previously published [18,20,21]. Yeast were sequentially transformed with bait plasmid and pACT2 library by the lithium acetate method. After auxotrophic and colony size selection, resulting clones were analyzed for expression of GAL4-dependent β-galactosidase. Plasmid DNA from those clones exhibiting β-galactosidase activity was isolated and retransformed into yeast strain Y190 with pGBT9-p30 to eliminate false positives. The sequence of inserts was determined by sequencing using specific primers and compared with the data base of the NCBI using the BLAST program. pGBT9-p30, pGBT9-p54 and pACT2-K were individually transformed in yeast and tested for β-galactosidase activity to exclude activation of gene reporter by itselves.</text><annotation id="3"><infon key="type">ExperimentalMethod</infon><infon key="PSIMI">0018</infon><location offset="5328" length="922"/><text>pGBT9-p30 and unrelated control protein pGBT9-p54 were independently used as baits to screen a pACT2 cDNA library from pig macrophages in Saccharomyces cerevisiae reporter strain Y190 as previously published [18,20,21]. Yeast were sequentially transformed with bait plasmid and pACT2 library by the lithium acetate method. After auxotrophic and colony size selection, resulting clones were analyzed for expression of GAL4-dependent β-galactosidase. Plasmid DNA from those clones exhibiting β-galactosidase activity was isolated and retransformed into yeast strain Y190 with pGBT9-p30 to eliminate false positives. The sequence of inserts was determined by sequencing using specific primers and compared with the data base of the NCBI using the BLAST program. pGBT9-p30, pGBT9-p54 and pACT2-K were individually transformed in yeast and tested for β-galactosidase activity to exclude activation of gene reporter by itselves.</text></annotation></passage><passage><infon key="type">paragraph</infon><offset>6254</offset><text>The different mutant truncations of p30 were individually transformed with pACT2-K in Y190 and resulting clones tested for expression of GAL4-dependent β-galactosidase. Similarly, different mutant truncations of hnRNP-K were transformed with pGBT9-p30 and tested.</text></passage><passage><infon key="type">title_2</infon><offset>6519</offset><text>GST pull-down experiments</text></passage><passage><infon key="type">paragraph</infon><offset>6545</offset><text>GST-hnRNP-K and GST proteins were produced in E. coli BL21 cells, previously transformed with vector pGEX-RNP-K or pGEX-4T. Cells were induced with 0.1 mM IPTG for 2 h at 37 °C. Bacteria were harvested and suspended in lysis buffer (PBS, 1% Triton X-100, 1 mM PMSF, 5 mM DTT, and anti-proteases), and sonicated on ice. GST-hnRNP-K and GST alone were purified from cleared lysates by mixing with glutathione-sepharose 4B beads (GE HealthCare), 5 ml of cleared lysate/400 μl of beads, for 1 h at 4 °C. After extensive washing, GST-hnRNP-K or GST beads were incubated in binding buffer (50 mM HEPES, ph 7.5, 50 mM NaCl, 0.1% Nonidet P-40 with protease inhibitor mixture (Roche Molecular Biochemical)) at 4 °C for 1 h with insect cell extracts containing either p30 or p54 ASFV proteins overexpressed in a baculovirus system [8]. Equal amounts of GST, GST-hnRNP-K and ASFV proteins p30 and p54 were used as judged by Coomasie Blue staining.</text><annotation id="4"><infon key="type">ExperimentalMethod</infon><infon key="PSIMI">0096</infon><location offset="6545" length="936"/><text>GST-hnRNP-K and GST proteins were produced in E. coli BL21 cells, previously transformed with vector pGEX-RNP-K or pGEX-4T. Cells were induced with 0.1 mM IPTG for 2 h at 37 °C. Bacteria were harvested and suspended in lysis buffer (PBS, 1% Triton X-100, 1 mM PMSF, 5 mM DTT, and anti-proteases), and sonicated on ice. GST-hnRNP-K and GST alone were purified from cleared lysates by mixing with glutathione-sepharose 4B beads (GE HealthCare), 5 ml of cleared lysate/400 μl of beads, for 1 h at 4 °C. After extensive washing, GST-hnRNP-K or GST beads were incubated in binding buffer (50 mM HEPES, ph 7.5, 50 mM NaCl, 0.1% Nonidet P-40 with protease inhibitor mixture (Roche Molecular Biochemical)) at 4 °C for 1 h with insect cell extracts containing either p30 or p54 ASFV proteins overexpressed in a baculovirus system [8]. Equal amounts of GST, GST-hnRNP-K and ASFV proteins p30 and p54 were used as judged by Coomasie Blue staining.</text></annotation></passage><passage><infon key="type">paragraph</infon><offset>7499</offset><text>Alternatively, monolayers of Vero cells infected with BA71V and lysed in 50 mM HEPES, ph 7.5, 50 mM NaCl, 0.1% Nonidet P-40 containing protease inhibitor, were similarly mixed with GST-hnRNP-K or GST beads. In all cases, after extensive washing, bound proteins were eluted and analyzed by Western blotting with anti-p30 monoclonal antibody (diluted 1:500) or anti-p54 serum (diluted 1:60).</text></passage><passage><infon key="type">title_2</infon><offset>7891</offset><text>Virus infections and immunofluorescence analyses</text></passage><passage><infon key="type">paragraph</infon><offset>7940</offset><text>Vero cells were grown in DMEM 5% onto cover slips, at 50–60% confluence, allowed to attached and then infected or mock infected with 1 pfu/cell of ASFV strain BA71V. Cells were fixed from 4 to 24 hpi in PBS-paraformaldehyde 3.8% and permeabilized in PBS-TX-100 0.1% for immunofluorescence analyses. In transient expression analysis pCMV-p30 was transfected in Vero cells using Fugene6 (Roche Molecular Biochemical) according to manufacturer’s indications.</text></passage><passage><infon key="type">paragraph</infon><offset>8401</offset><text>Anti-hnRNP-K rabbit serum and mouse monoclonal anti-p30 were used at 1:400 and 1:100, respectively. Secondary antibodies used were Alexa 488-conjugated goat anti-rabbit IgG (Molecular Probes) and Rhodamine Red conjugated goat anti-mouse IgG (Molecular Probes), both at dilution 1:300.</text></passage><passage><infon key="type">paragraph</infon><offset>8686</offset><text>Incorporation of 5-fluorouridine (FU; Sigma) into nascent RNA was determined as previously [22]. Briefly, transfected or BA71V infected cells were pulse labelled with 5 mM FU at 37 °C for 20 min. After washing with PBS to remove residual FU, cells were fixed and permeabilized as described. Monoclonal antibody against halogenated UTP (anti-BrU; Sigma) was used diluted 1:500 to label nascent RNA. Specific fluorescence was measured using Lasersharp Processing 3.2 program (BioRad).</text></passage><passage><infon key="type">paragraph</infon><offset>9173</offset><text>Specificity of labelling and absence of signal crossover was excluded in all cases by examination of single labelled control samples, including labelling controls with omission of primary antibody. When indicated, viral factories and cell nuclei were identified by direct staining of cells with Hoechst 33342 1 μg/ml (Sigma). Finally, cells were mounted onto slides using Fluorsave reagent (Calbiochem).</text></passage><passage><infon key="type">paragraph</infon><offset>9579</offset><text>Conventional microscopy was carried out in a Leica photomicroscope with a digital camera and digitized images were obtained with Qwin program (Leica).</text></passage><passage><infon key="type">paragraph</infon><offset>9730</offset><text>Confocal microscopy was carried out on an MRC1024 system (BioRad) mounted on a Nikon Eclipse 300 microscope equipped with 63 and 100X objectives. Statistical analysis of colocalization was performed using Lasersharp Processing 3.2 program (BioRad).</text></passage><passage><infon key="type">title_2</infon><offset>9979</offset><text>Preparation of nuclear and cytoplasmic extracts</text></passage><passage><infon key="type">paragraph</infon><offset>10027</offset><text>Preconfluent monolayers of Vero cells were mock infected or infected with ASFV strain BA71V. Cells were washed and harvested from 0 to 24 hpi in cold PBS. Isolation of nuclear and cytoplasmic fractions was performed as described previously [23]. Briefly, cell pellets were suspended in three volumes of hypotonic buffer and homogenization was carried out with a glass Dounce homogenizator. After centrifugation at 3300 × g for 15 min, supernatant was considered as the cytoplasmic fraction while pellets containing nuclei were suspended in half volume of low salt buffer. Extraction of nuclei was performed by adding 1 volume of high salt buffer for 30 min followed by centrifugation at 25000 × g. Resulting supernatant was considered as the nuclear fraction. After dialysis, 20 μg from each cytosolic sample and 13 μg from each nuclear sample were analyzed by Western blot with specific antibodies (anti-p30, anti-hnRNP-K and anti-β-tubulin diluted 1:500, 1:10.000 and 1:500, respectively). Quality of fractionation process was assessed by detection of β-tubulin on both nuclear and cytosolic samples. Bands obtained corresponding to hnRNP-K were densitometrically quantified using an image analyzer with TINA software package (Raytest).</text></passage><passage><infon key="type">title_1</infon><offset>11280</offset><text>Results</text></passage><passage><infon key="type">title_2</infon><offset>11288</offset><text>Identification of hnRNP-K as cellular interacting protein with ASFV p30</text></passage><passage><infon key="type">paragraph</infon><offset>11360</offset><text>To identify cellular proteins interacting with ASFV early protein p30, yeast two-hybrid system was used to screen a porcine macrophage cDNA library. After selection from a total of 5 × 106 transformants screened, two potential positive clones were obtained in the reporter gene assay. DNA sequence analysis showed that cDNA contained in these clones, identical in size and composition, matched the cDNA sequence encoding hnRNP-K. cDNA sequences from positive clones represent nucleotides from 169 to 870 of the hnRNP-K cDNA sequence (GeneBank™ accession number 241477), with 98% nucleotide identity, corresponding to amino acid residues 13–246 of hnRNP-K protein. To confirm this result, the plasmid contained in these two clones was isolated and retransformed together with pGBT9-p30 detecting β-galactosidase activity. Conversely, clones obtained screening the library with pGBT9-p54 never encoded a similar sequence. Moreover, no reporter gene activity was detected in clones transformed with pACT2-K alone, excluding activation of gene reporter by itself.</text><annotation id="5"><infon key="type">ExperimentalMethod</infon><infon key="PSIMI">0018</infon><location offset="11360" length="663"/><text>To identify cellular proteins interacting with ASFV early protein p30, yeast two-hybrid system was used to screen a porcine macrophage cDNA library. After selection from a total of 5 × 106 transformants screened, two potential positive clones were obtained in the reporter gene assay. DNA sequence analysis showed that cDNA contained in these clones, identical in size and composition, matched the cDNA sequence encoding hnRNP-K. cDNA sequences from positive clones represent nucleotides from 169 to 870 of the hnRNP-K cDNA sequence (GeneBank™ accession number 241477), with 98% nucleotide identity, corresponding to amino acid residues 13–246 of hnRNP-K protein.</text></annotation></passage><passage><infon key="type">title_2</infon><offset>12428</offset><text>p30 binds directly to hnRNP-K in vitro</text></passage><passage><infon key="type">paragraph</infon><offset>12467</offset><text>The interaction was further confirmed by in vitro binding assays using a GST-hnRNP-K fusion protein bound to glutathione-sepharose 4B beads. GST pull-down experiments were carried out followed by Western blot with specific antibodies. First, p30 and another unrelated ASFV protein (in this case, p54 as negative control) were used to bind GST fusion protein or GST alone. Protein p30, and not p54, was retained in the presence of GST-hnRNP K, showing a band of appropriate size (30 kDa) for p30 in Western blotting. This band did not appear in the presence of GST alone, indicating specific interaction of p30 with hnRNP K and not with GST (Fig. 1A). Identical results were obtained in subsequent experiments using BA71V infected or mock-infected cells extracts instead of baculovirus infected cell extracts in the pull-down assay (Fig. 1B).</text><annotation id="6"><infon key="type">ExperimentalMethod</infon><infon key="PSIMI">0096</infon><location offset="12467" length="841"/><text>The interaction was further confirmed by in vitro binding assays using a GST-hnRNP-K fusion protein bound to glutathione-sepharose 4B beads. GST pull-down experiments were carried out followed by Western blot with specific antibodies. First, p30 and another unrelated ASFV protein (in this case, p54 as negative control) were used to bind GST fusion protein or GST alone. Protein p30, and not p54, was retained in the presence of GST-hnRNP K, showing a band of appropriate size (30 kDa) for p30 in Western blotting. This band did not appear in the presence of GST alone, indicating specific interaction of p30 with hnRNP K and not with GST (Fig. 1A). Identical results were obtained in subsequent experiments using BA71V infected or mock-infected cells extracts instead of baculovirus infected cell extracts in the pull-down assay (Fig. 1B).</text></annotation></passage><passage><infon key="type">title_2</infon><offset>13310</offset><text>Mapping the interacting domains of p30 and hnRNP-K</text></passage><passage><infon key="type">paragraph</infon><offset>13361</offset><text>To examine the regions of both proteins involved in this interaction, different truncations of p30 fused to GAL4-BD domain and different truncations of hnRNP-K fused to GAL4-AD domain were tested for interaction (Fig. 2). As p30 sequence does not contain any previously characterized functional domain, we analyzed independently p30 amino terminus, central region and carboxy terminus fragments (1–70, 1–140 and 140–204 aa residues) for hnRNP-K interaction. In addition, diverse truncations of hnRNP-K were performed attending to previously well characterized functional domains [10] and tested for interaction using the yeast two-hybrid system. The results showed that none of the three different p30 truncations interacted with hnRNP-K (Fig. 2A). On the other hand, we could determine that the hnRNP-K fragment from amino acid residue 35–197 contained the interacting region with p30 (Fig. 2B). This region harbours KH1 and KH2 domains, identical each other, which have been previously identified as functional elements responsible for RNA binding.</text><annotation id="7"><infon key="type">ExperimentalMethod</infon><infon key="PSIMI">0018</infon><location offset="13819" length="438"/><text>In addition, diverse truncations of hnRNP-K were performed attending to previously well characterized functional domains [10] and tested for interaction using the yeast two-hybrid system. The results showed that none of the three different p30 truncations interacted with hnRNP-K (Fig. 2A). On the other hand, we could determine that the hnRNP-K fragment from amino acid residue 35–197 contained the interacting region with p30 (Fig. 2B).</text></annotation></passage><passage><infon key="type">title_2</infon><offset>14420</offset><text>Partial colocalization of protein p30 and hnRNP-K in ASFV infected cells</text></passage><passage><infon key="type">paragraph</infon><offset>14493</offset><text>To ascertain the time in infection and the subcellular compartment at which the interaction occurs, ASFV infected cells were examined by confocal laser scanning microscopy at different times post infection (at least 30 infected cells were analyzed for each time point at 0, 6, 8 and 12 hpi). Newly synthesized viral protein p30 could not be detected in the nucleus or cytoplasm of examined cells before 8 hpi. Since that time point, p30 and hnRNP-K were found to colocalize in discrete areas within the nucleus of infected cells. Statistical analysis of colocalization showed that the totality of protein p30 present in the nucleus was detected colocalizing with hnRNP-K since 12 hpi (Fig. 3B). In contrast, most hnRNP-K was detected also in other parts of the nucleus exhibiting no colocalization with p30, indicating a partial colocalization of hnRNP-K with p30. Interestingly, in the cytoplasmic region of those infected cells hnRNP-K was barely detected and colocalization percentages were not significant (data not shown).</text><annotation id="8"><infon key="type">ExperimentalMethod</infon><infon key="PSIMI">0416</infon><location offset="14493" length="291"/><text>To ascertain the time in infection and the subcellular compartment at which the interaction occurs, ASFV infected cells were examined by confocal laser scanning microscopy at different times post infection (at least 30 infected cells were analyzed for each time point at 0, 6, 8 and 12 hpi).</text></annotation></passage><passage><infon key="type">title_2</infon><offset>15521</offset><text>ASFV infection modifies hnRNP-K distribution</text></passage><passage><infon key="type">paragraph</infon><offset>15566</offset><text>Subcellular distribution of p30 and hnRNP-K were analyzed by immunofluorescence microscopy in ASFV or mock infected cells. ASFV infection resulted in an intensification of nuclear, but not cytoplasmic, staining of hnRNP-K when compared to uninfected cells. When nuclei of infected cells were examined in detail, nuclear hnRNP-K was detected in characteristic granular structures coincident with areas completely devoid of nucleic acid staining. Interestingly, these kind of hnRNP-K accumulation was also observed in cells transiently expressing p30 (pCMV-p30), but not in mock-infected cells, suggesting the involvement of p30 on these changes (Fig. 4) during ASFV infection.</text><annotation id="9"><infon key="type">ExperimentalMethod</infon><infon key="PSIMI">0416</infon><location offset="15566" length="675"/><text>Subcellular distribution of p30 and hnRNP-K were analyzed by immunofluorescence microscopy in ASFV or mock infected cells. ASFV infection resulted in an intensification of nuclear, but not cytoplasmic, staining of hnRNP-K when compared to uninfected cells. When nuclei of infected cells were examined in detail, nuclear hnRNP-K was detected in characteristic granular structures coincident with areas completely devoid of nucleic acid staining. Interestingly, these kind of hnRNP-K accumulation was also observed in cells transiently expressing p30 (pCMV-p30), but not in mock-infected cells, suggesting the involvement of p30 on these changes (Fig. 4) during ASFV infection.</text></annotation></passage><passage><infon key="type">paragraph</infon><offset>16242</offset><text>To confirm the retention of hnRNP-K in the nucleus of infected cells observed by immunofluorescence, the levels of hnRNP-K were assessed by Western blot at different times post infection using total, cytoplasmic and nuclear protein cell extracts. Total levels of hnRNP-K (Fig. 5A) were determined as infection proceeded (monitored by detection of p30) in order to discard that these changes could be to due changes in newly synthesized hnRNP-K or protein degradation. While no changes in total hnRNP-K levels were observed, quantitative analysis revealed a reduction of hnRNP-K levels in cytoplasm protein extracts from 12 hpi until the end of the infectious cycle (Fig. 5B). This reduction was in agreement with the observed increase of nuclear hnRNP-K levels, as judged by Western blot analysis. These results are consistent with the immunofluorescence analysis and indicate nuclear accumulation of hnRNP-K during ASFV infection.</text></passage><passage><infon key="type">paragraph</infon><offset>17174</offset><text>These changes in hnRNP-K distribution might disrupt the normal behaviour of this ribonucleoprotein which is involved in diverse biological processes including regulation of transcription and translation. To examine the transcriptional activity in ASFV infected cells we performed immunodetection of nascent RNA after FU pulse labelling (Fig. 5C). When compared with mock-infected cells, the incorporation of FU into nascent RNA was almost completely abolished in infected cells from 12 hpi, coincident with the time point at which hnRNP-K redistribution was observed.</text></passage><passage><infon key="type">title_1</infon><offset>17742</offset><text>Discussion</text></passage><passage><infon key="type">paragraph</infon><offset>17753</offset><text>Infection of eukaryotic cells with large DNA viruses often results in extensive interactions of viral gene products with macromolecular pathways of the host cell. By using the yeast two-hybrid system, we identified cellular hnRNP-K as an interacting protein with ASFV early protein p30. This interaction was further confirmed by an in vitro GST-fusion pull-down assay, using either p30 obtained from baculovirus system or ASFV infected cell extracts.</text><annotation id="10"><infon key="type">ExperimentalMethod</infon><infon key="PSIMI">0018</infon><location offset="17916" length="123"/><text>By using the yeast two-hybrid system, we identified cellular hnRNP-K as an interacting protein with ASFV early protein p30.</text></annotation><annotation id="11"><infon key="type">ExperimentalMethod</infon><infon key="PSIMI">0096</infon><location offset="18040" length="163"/><text>This interaction was further confirmed by an in vitro GST-fusion pull-down assay, using either p30 obtained from baculovirus system or ASFV infected cell extracts.</text></annotation></passage><passage><infon key="type">paragraph</infon><offset>18204</offset><text>hnRNP-K is closely coupled to gene expression [15,24] and signal transduction pathways [16,25]. One feature which distinguishes hnRNP-K from other hnRNPs is the presence of three repeated K homology motives (KH) which are responsible for RNA-binding [26–28]. Interestingly, the p30 interacting region within hnRNP-K contains KH1 and KH2 motives, suggesting that the interaction described might modify hnRNP-K functions such as processing and export of the cellular mRNAs than on signal transduction pathways.</text></passage><passage><infon key="type">paragraph</infon><offset>18715</offset><text>hnRNP-K has been previously described to interact with several proteins from diverse viruses. Core protein from Hepatitis C virus (HCV) and Dengue virus (DEN), are proposed to relieve the repressive effect of hnRNP-K on transcription regulation of different human genes in vivo, disrupting the multiple functions of hnRNP-K and contributing to virus pathogenesis [11,12]. Studies with phosphoprotein IE63 (also named ICP27) from Herpes simplex virus (HSV) suggest that an IE63-mediated phosphorylation of hnRNP-K by casein kinase 2, results in inhibition of binding to RNA, affecting transport of cellular mRNAs and altering the subcellular location of hnRNP-K [13]. Nevertheless, no homology sequence in nucleotides or amino acids has been found when comparing these virus proteins interacting with hnRNP-K, including p30, indicating that this common interaction could occur in multiple and diverse ways.</text></passage><passage><infon key="type">paragraph</infon><offset>19621</offset><text>During ASFV infection, hnRNP-K normal function could be affected since changes related to hnRNP-K subcellular distribution are observed. First, accumulation of hnRNP-K within the nucleus of ASFV infected cells was evident and subsequently the levels of cytoplasmic hnRNP-K decreased while nuclear levels were increased, as infection proceeded, supporting the idea that accumulation of hnRNP-K within nucleus is most likely due to relocation from cytoplasm. Changes in hnRNP-K subcellular distribution have been reported previously in poliovirus infection where virus infection affects the normal nucleo-cytoplasmic trafficking of the host cell [29]. Second, this hnRNP-K accumulation is coincident with the appearance of granular structures in the nucleus where the ribonucleoprotein is detected. Since no nucleic acids can be detected in these areas, these structures could represent inactive sites within the nucleus where hnRNP-K remains sequestered as consequence of infection, as postulated for HSV1 [13]. Similar structures have been previously reported during HCV infection. In this case, HCV core protein and hnRNP-K also colocalized in granules in the nucleus [12]. The presence of p30 in nucleus colocalizing with hnRNP-K suggests an involvement of this interaction in the appearance of these characteristic structures. Moreover, the identification of these structures also in cells transiently expressing p30 supports this idea.</text></passage><passage><infon key="type">paragraph</infon><offset>21061</offset><text>Interestingly, neither conventional nuclear localization nor classical nuclear import signal have been previously found within ASFV protein p30 sequence, since it exhibits a predominantly cytoplasmic distribution. In this report we have demonstrated that small amounts of p30 are also present in the nucleus of the infected cell, so it can not be excluded that interaction with shuttling protein in cytoplasm could facilitate p30 traffic to the cell nucleus. Nevertheless, colocalization of both proteins in the cytoplasm during infection was not detectable by immunofluorescence, probably because of the low relative abundance of hnRNP-K in cytoplasm and its shuttling properties which difficult its visualization by immunofluorescence microscopy.</text></passage><passage><infon key="type">paragraph</infon><offset>21810</offset><text>In conclusion, protein p30 could have further regulatory actions associated to its specific binding to hnRNP-K protein in the nucleus of infected cells. It is well known that viruses have evolved different mechanisms to alter host cell transcription and translation to promote transcription of its own DNA [30]. Here, we confirmed that all changes observed in hnRNP-K distribution during ASFV infection take place simultaneously with an extraordinary reduction in 5-fluouridine (FU) incorporation into nascent RNA, which represents an alteration in the cellular transcriptional activity. One way to inhibit cellular transcription is the recruitment of host cell RNA polymerase II. Nevertheless this is not a requirement for ASFV, since α-amanitin does not inhibit the production of infectious virus [31]. However, in cell systems previously studied (macrophages and Vero cells), ASFV infection produces a general shut-off of protein synthesis that affects up to 65% of the cellular proteins [2,32,33]. This inhibition of protein synthesis is detectable very early after ASFV infection, so it will be interesting to determine whether the interaction here described is contributing to the general host cell shut-off or to a concrete cellular pathway.</text></passage><passage><infon key="type">title</infon><offset>23060</offset><text>References</text></passage><passage><infon key="fpage">135</infon><infon key="lpage">143</infon><infon key="name_0">surname:Dixon;given-names:L.K.</infon><infon key="name_1">surname:Escribano;given-names:J.M.</infon><infon key="name_10">surname:Ball;given-names:L.A.</infon><infon key="name_2">surname:Martins;given-names:C.</infon><infon key="name_3">surname:Rock;given-names:D.L.</infon><infon key="name_4">surname:Salas;given-names:M.L.</infon><infon key="name_5">surname:Wilkinson;given-names:P.J.</infon><infon key="name_6">surname:Fauquet;given-names:C.M.</infon><infon key="name_7">surname:Mayo;given-names:M.A.</infon><infon key="name_8">surname:Maniloff;given-names:J.</infon><infon key="name_9">surname:Desselberger;given-names:U.</infon><infon key="source">Virus Taxonomy, VIII Report of the ICTV</infon><infon key="type">ref</infon><infon key="year">2004</infon><offset>23071</offset></passage><passage><infon key="fpage">221</infon><infon key="lpage">232</infon><infon key="name_0">surname:Escribano;given-names:J.M.</infon><infon key="name_1">surname:Tabares;given-names:E.</infon><infon key="pub-id_pmid">3101652</infon><infon key="source">Arch. Virol.</infon><infon key="type">ref</infon><infon key="volume">92</infon><infon key="year">1987</infon><offset>23072</offset><text>Proteins specified by African swine fever virus: V. Identification of immediate early, early and late proteins</text></passage><passage><infon key="fpage">368</infon><infon key="lpage">373</infon><infon key="name_0">surname:Afonso;given-names:C.L.</infon><infon key="name_1">surname:Alcaraz;given-names:C.</infon><infon key="name_2">surname:Brun;given-names:A.</infon><infon key="name_3">surname:Sussman;given-names:M.D.</infon><infon key="name_4">surname:Onisk;given-names:D.V.</infon><infon key="name_5">surname:Escribano;given-names:J.M.</infon><infon key="name_6">surname:Rock;given-names:D.L.</infon><infon key="pub-id_pmid">1604821</infon><infon key="source">Virology</infon><infon key="type">ref</infon><infon key="volume">189</infon><infon key="year">1992</infon><offset>23183</offset><text>Characterization of p30, a highly antigenic membrane and secreted protein of African swine fever virus</text></passage><passage><infon key="fpage">2475</infon><infon key="lpage">2485</infon><infon key="name_0">surname:Prados;given-names:F.J.</infon><infon key="name_1">surname:Vinuela;given-names:E.</infon><infon key="name_2">surname:Alcami;given-names:A.</infon><infon key="pub-id_pmid">8474154</infon><infon key="source">J. Virol.</infon><infon key="type">ref</infon><infon key="volume">67</infon><infon key="year">1993</infon><offset>23286</offset><text>Sequence and characterization of the major early phosphoprotein p32 of African swine fever virus</text></passage><passage><infon key="fpage">191</infon><infon key="lpage">196</infon><infon key="name_0">surname:Alcaraz;given-names:C.</infon><infon key="name_1">surname:De Diego;given-names:M.</infon><infon key="name_2">surname:Pastor;given-names:M.J.</infon><infon key="name_3">surname:Escribano;given-names:J.M.</infon><infon key="pub-id_pmid">2094444</infon><infon key="source">J. Vet. Diagn. Invest.</infon><infon key="type">ref</infon><infon key="volume">2</infon><infon key="year">1990</infon><offset>23383</offset><text>Comparison of a radioimmunoprecipitation assay to immunoblotting and ELISA for detection of antibody to African swine fever virus</text></passage><passage><infon key="fpage">461</infon><infon key="lpage">471</infon><infon key="name_0">surname:Gomez-Puertas;given-names:P.</infon><infon key="name_1">surname:Rodriguez;given-names:F.</infon><infon key="name_2">surname:Oviedo;given-names:J.M.</infon><infon key="name_3">surname:Brun;given-names:A.</infon><infon key="name_4">surname:Alonso;given-names:C.</infon><infon key="name_5">surname:Escribano;given-names:J.M.</infon><infon key="pub-id_pmid">9568043</infon><infon key="source">Virology</infon><infon key="type">ref</infon><infon key="volume">243</infon><infon key="year">1998</infon><offset>23513</offset><text>The African swine fever virus proteins p54 and p30 are involved in two distinct steps of virus attachment and both contribute to the antibody-mediated protective immune response</text></passage><passage><infon key="fpage">5689</infon><infon key="lpage">5694</infon><infon key="name_0">surname:Gomez-Puertas;given-names:P.</infon><infon key="name_1">surname:Rodriguez;given-names:F.</infon><infon key="name_2">surname:Oviedo;given-names:J.M.</infon><infon key="name_3">surname:Ramiro-Ibanez;given-names:F.</infon><infon key="name_4">surname:Ruiz-Gonzalvo;given-names:F.</infon><infon key="name_5">surname:Alonso;given-names:C.</infon><infon key="name_6">surname:Escribano;given-names:J.M.</infon><infon key="pub-id_pmid">8764090</infon><infon key="source">J. Virol.</infon><infon key="type">ref</infon><infon key="volume">70</infon><infon key="year">1996</infon><offset>23691</offset><text>Neutralizing antibodies to different proteins of African swine fever virus inhibit both virus attachment and internalization</text></passage><passage><infon key="fpage">27</infon><infon key="lpage">35</infon><infon key="name_0">surname:Oviedo;given-names:J.M.</infon><infon key="name_1">surname:Rodriguez;given-names:F.</infon><infon key="name_2">surname:Gomez-Puertas;given-names:P.</infon><infon key="name_3">surname:Brun;given-names:A.</infon><infon key="name_4">surname:Gomez;given-names:N.</infon><infon key="name_5">surname:Alonso;given-names:C.</infon><infon key="name_6">surname:Escribano;given-names:J.M.</infon><infon key="pub-id_pmid">9029527</infon><infon key="source">J. Virol. Methods</infon><infon key="type">ref</infon><infon key="volume">64</infon><infon key="year">1997</infon><offset>23816</offset><text>High level expression of the major antigenic African swine fever virus proteins p54 and p30 in baculovirus and their potential use as diagnostic reagents</text></passage><passage><infon key="fpage">629</infon><infon key="lpage">638</infon><infon key="name_0">surname:Bomsztyk;given-names:K.</infon><infon key="name_1">surname:Denisenko;given-names:O.</infon><infon key="name_2">surname:Ostrowski;given-names:J.</infon><infon key="pub-id_pmid">15170860</infon><infon key="source">Bioessays</infon><infon key="type">ref</infon><infon key="volume">26</infon><infon key="year">2004</infon><offset>23970</offset><text>hnRNP K: one protein multiple processes</text></passage><passage><infon key="fpage">113</infon><infon key="lpage">115</infon><infon key="name_0">surname:Bomsztyk;given-names:K.</infon><infon key="name_1">surname:Van Seuningen;given-names:I.</infon><infon key="name_2">surname:Suzuki;given-names:H.</infon><infon key="name_3">surname:Denisenko;given-names:O.</infon><infon key="name_4">surname:Ostrowski;given-names:J.</infon><infon key="pub-id_pmid">9042948</infon><infon key="source">FEBS Lett.</infon><infon key="type">ref</infon><infon key="volume">403</infon><infon key="year">1997</infon><offset>24010</offset><text>Diverse molecular interactions of the hnRNP-K protein</text></passage><passage><infon key="fpage">569</infon><infon key="lpage">577</infon><infon key="name_0">surname:Chang;given-names:C.J.</infon><infon key="name_1">surname:Luh;given-names:H.W.</infon><infon key="name_2">surname:Wang;given-names:S.H.</infon><infon key="name_3">surname:Lin;given-names:H.J.</infon><infon key="name_4">surname:Lee;given-names:S.C.</infon><infon key="name_5">surname:Hu;given-names:S.T.</infon><infon key="pub-id_pmid">11747608</infon><infon key="source">DNA Cell Biol.</infon><infon key="type">ref</infon><infon key="volume">20</infon><infon key="year">2001</infon><offset>24064</offset><text>The heterogeneous nuclear ribonucleoprotein K (hnRNP-K) interacts with dengue virus core protein</text></passage><passage><infon key="fpage">17651</infon><infon key="lpage">17659</infon><infon key="name_0">surname:Hsieh;given-names:T.Y.</infon><infon key="name_1">surname:Matsumoto;given-names:M.</infon><infon key="name_2">surname:Chou;given-names:H.C.</infon><infon key="name_3">surname:Schneider;given-names:R.</infon><infon key="name_4">surname:Hwang;given-names:S.B.</infon><infon key="name_5">surname:Lee;given-names:A.S.</infon><infon key="name_6">surname:Lai;given-names:M.M.</infon><infon key="pub-id_pmid">9651361</infon><infon key="source">J. Biol. Chem.</infon><infon key="type">ref</infon><infon key="volume">273</infon><infon key="year">1998</infon><offset>24161</offset><text>Hepatitis C virus core protein interacts with heterogeneous nuclear ribonucleoprotein K</text></passage><passage><infon key="fpage">28991</infon><infon key="lpage">28998</infon><infon key="name_0">surname:Wadd;given-names:S.</infon><infon key="name_1">surname:Bryant;given-names:H.</infon><infon key="name_2">surname:Filhol;given-names:O.</infon><infon key="name_3">surname:Scott;given-names:J.E.</infon><infon key="name_4">surname:Hsieh;given-names:T.Y.</infon><infon key="name_5">surname:Everett;given-names:R.D.</infon><infon key="name_6">surname:Clements;given-names:J.B.</infon><infon key="pub-id_pmid">10506147</infon><infon key="source">J. Biol. Chem.</infon><infon key="type">ref</infon><infon key="volume">274</infon><infon key="year">1999</infon><offset>24249</offset><text>The multifunctional herpes simplex virus IE63 protein interacts with heterogeneous ribonucleoprotein K and with casein kinase 2</text></passage><passage><infon key="fpage">212</infon><infon key="lpage">221</infon><infon key="name_0">surname:Burnham;given-names:A.J.</infon><infon key="name_1">surname:Gong;given-names:L.</infon><infon key="name_2">surname:Hardy;given-names:R.W.</infon><infon key="pub-id_pmid">17561226</infon><infon key="source">Virology</infon><infon key="type">ref</infon><infon key="volume">367</infon><infon key="year">2007</infon><offset>24377</offset><text>Heterogeneous nuclear ribonuclear protein K interacts with Sindbis virus nonstructural proteins and viral subgenomic mRNA</text></passage><passage><infon key="fpage">2350</infon><infon key="lpage">2360</infon><infon key="name_0">surname:Michelotti;given-names:E.F.</infon><infon key="name_1">surname:Michelotti;given-names:G.A.</infon><infon key="name_2">surname:Aronsohn;given-names:A.I.</infon><infon key="name_3">surname:Levens;given-names:D.</infon><infon key="pub-id_pmid">8628302</infon><infon key="source">Mol. Cell Biol.</infon><infon key="type">ref</infon><infon key="volume">16</infon><infon key="year">1996</infon><offset>24499</offset><text>Heterogeneous nuclear ribonucleoprotein K is a transcription factor</text></passage><passage><infon key="fpage">26976</infon><infon key="lpage">26985</infon><infon key="name_0">surname:Van Seuningen;given-names:I.</infon><infon key="name_1">surname:Ostrowski;given-names:J.</infon><infon key="name_2">surname:Bustelo;given-names:X.R.</infon><infon key="name_3">surname:Sleath;given-names:P.R.</infon><infon key="name_4">surname:Bomsztyk;given-names:K.</infon><infon key="pub-id_pmid">7592945</infon><infon key="source">J. Biol. Chem.</infon><infon key="type">ref</infon><infon key="volume">270</infon><infon key="year">1995</infon><offset>24567</offset><text>The K protein domain that recruits the interleukin 1-responsive K protein kinase lies adjacent to a cluster of c-Src and Vav SH3-binding sites. Implications that K protein acts as a docking platform</text></passage><passage><infon key="name_0">surname:Mikula;given-names:M.</infon><infon key="name_1">surname:Dzwonek;given-names:A.</infon><infon key="name_2">surname:Karczmarski;given-names:J.</infon><infon key="name_3">surname:Rubel;given-names:T.</infon><infon key="name_4">surname:Dadlez;given-names:M.</infon><infon key="name_5">surname:Wyrwicz;given-names:L.S.</infon><infon key="name_6">surname:Bomsztyk;given-names:K.</infon><infon key="name_7">surname:Ostrowski;given-names:J.</infon><infon key="source">Proteomics</infon><infon key="type">ref</infon><infon key="year">2006</infon><offset>24766</offset><text>Landscape of the hnRNP K protein-protein interactome</text></passage><passage><infon key="fpage">9819</infon><infon key="lpage">9827</infon><infon key="name_0">surname:Alonso;given-names:C.</infon><infon key="pub-id_pmid">11559815</infon><infon key="source">J. Virol.</infon><infon key="type">ref</infon><infon key="volume">75</infon><infon key="year">2001</infon><offset>24819</offset><text>African swine fever virus protein p54 interacts with the microtubular motor complex through direct binding to light-chain dynein</text></passage><passage><infon key="fpage">562</infon><infon key="lpage">565</infon><infon key="name_0">surname:Miskin;given-names:J.E.</infon><infon key="name_1">surname:Abrams;given-names:C.C.</infon><infon key="name_2">surname:Goatley;given-names:L.C.</infon><infon key="name_3">surname:Dixon;given-names:L.K.</infon><infon key="pub-id_pmid">9677199</infon><infon key="source">Science</infon><infon key="type">ref</infon><infon key="volume">281</infon><infon key="year">1998</infon><offset>24948</offset><text>A viral mechanism for inhibition of the cellular phosphatase calcineurin</text></passage><passage><infon key="fpage">561</infon><infon key="lpage">572</infon><infon key="name_0">surname:Galindo;given-names:I.</infon><infon key="name_1">surname:Hernaez;given-names:B.</infon><infon key="name_2">surname:Diaz-Gil;given-names:G.</infon><infon key="name_3">surname:Escribano;given-names:J.M.</infon><infon key="name_4">surname:Alonso;given-names:C.</infon><infon key="pub-id_pmid">18329683</infon><infon key="source">Virology</infon><infon key="type">ref</infon><infon key="volume">375</infon><infon key="year">2008</infon><offset>25021</offset><text>A179L, a viral Bcl-2 homologue, targets the core Bcl-2 apoptotic machinery and its upstream BH3 activators with selective binding restrictions for Bid and Noxa</text></passage><passage><infon key="fpage">2923</infon><infon key="lpage">2929</infon><infon key="name_0">surname:Rivera;given-names:J.</infon><infon key="name_1">surname:Abrams;given-names:C.</infon><infon key="name_2">surname:Hernaez;given-names:B.</infon><infon key="name_3">surname:Alcazar;given-names:A.</infon><infon key="name_4">surname:Escribano;given-names:J.M.</infon><infon key="name_5">surname:Dixon;given-names:L.</infon><infon key="name_6">surname:Alonso;given-names:C.</infon><infon key="pub-id_pmid">17215279</infon><infon key="source">J. Virol.</infon><infon key="type">ref</infon><infon key="volume">81</infon><infon key="year">2007</infon><offset>25181</offset><text>The MyD116 African swine fever virus homologue interacts with the catalytic subunit of protein phosphatase 1 and activates its phosphatase activity</text></passage><passage><infon key="fpage">283</infon><infon key="lpage">292</infon><infon key="name_0">surname:Boisvert;given-names:F.M.</infon><infon key="name_1">surname:Hendzel;given-names:M.J.</infon><infon key="name_2">surname:Bazett-Jones;given-names:D.P.</infon><infon key="pub-id_pmid">10648561</infon><infon key="source">J. Cell Biol.</infon><infon key="type">ref</infon><infon key="volume">148</infon><infon key="year">2000</infon><offset>25329</offset><text>Promyelocytic leukemia (PML) nuclear bodies are protein structures that do not accumulate RNA</text></passage><passage><infon key="fpage">12.3</infon><infon key="lpage">12.5</infon><infon key="name_0">surname:Abmayr;given-names:S.M.</infon><infon key="name_1">surname:Workman;given-names:J.L.</infon><infon key="name_2">surname:Ausubel;given-names:F.M.B.R.</infon><infon key="name_3">surname:Brent;given-names:R.</infon><infon key="name_4">surname:Kingston;given-names:R.E.</infon><infon key="name_5">surname:Moore;given-names:D.D.</infon><infon key="name_6">surname:Siedman;given-names:J.G.</infon><infon key="name_7">surname:Smith;given-names:J.A.</infon><infon key="name_8">surname:Struhl;given-names:K.</infon><infon key="source">Short Protocols in Molecular Biology</infon><infon key="type">ref</infon><infon key="year">1992</infon><offset>25423</offset></passage><passage><infon key="fpage">73</infon><infon key="lpage">78</infon><infon key="name_0">surname:Gorlach;given-names:M.</infon><infon key="name_1">surname:Burd;given-names:C.G.</infon><infon key="name_2">surname:Portman;given-names:D.S.</infon><infon key="name_3">surname:Dreyfuss;given-names:G.</infon><infon key="pub-id_pmid">8232298</infon><infon key="source">Mol. Biol. Rep.</infon><infon key="type">ref</infon><infon key="volume">18</infon><infon key="year">1993</infon><offset>25424</offset><text>The hnRNP proteins</text></passage><passage><infon key="fpage">9044</infon><infon key="lpage">9049</infon><infon key="name_0">surname:Ostrowski;given-names:J.</infon><infon key="name_1">surname:Kawata;given-names:Y.</infon><infon key="name_2">surname:Schullery;given-names:D.S.</infon><infon key="name_3">surname:Denisenko;given-names:O.N.</infon><infon key="name_4">surname:Higaki;given-names:Y.</infon><infon key="name_5">surname:Abrass;given-names:C.K.</infon><infon key="name_6">surname:Bomsztyk;given-names:K.</infon><infon key="pub-id_pmid">11470915</infon><infon key="source">Proc. Natl. Acad. Sci. USA</infon><infon key="type">ref</infon><infon key="volume">98</infon><infon key="year">2001</infon><offset>25443</offset><text>Insulin alters heterogeneous nuclear ribonucleoprotein K protein binding to DNA and RNA</text></passage><passage><infon key="fpage">425</infon><infon key="lpage">431</infon><infon key="name_0">surname:Dejgaard;given-names:K.</infon><infon key="name_1">surname:Leffers;given-names:H.</infon><infon key="pub-id_pmid">8917439</infon><infon key="source">Eur. J. Biochem.</infon><infon key="type">ref</infon><infon key="volume">241</infon><infon key="year">1996</infon><offset>25531</offset><text>Characterisation of the nucleic-acid-binding activity of KH domains. Different properties of different domains</text></passage><passage><infon key="fpage">638</infon><infon key="lpage">643</infon><infon key="name_0">surname:Grishin;given-names:N.V.</infon><infon key="pub-id_pmid">11160884</infon><infon key="source">Nucleic Acids Res.</infon><infon key="type">ref</infon><infon key="volume">29</infon><infon key="year">2001</infon><offset>25642</offset><text>KH domain: one motif, twofolds</text></passage><passage><infon key="fpage">33</infon><infon key="lpage">39</infon><infon key="name_0">surname:Siomi;given-names:H.</infon><infon key="name_1">surname:Choi;given-names:M.</infon><infon key="name_2">surname:Siomi;given-names:M.C.</infon><infon key="name_3">surname:Nussbaum;given-names:R.L.</infon><infon key="name_4">surname:Dreyfuss;given-names:G.</infon><infon key="pub-id_pmid">8156595</infon><infon key="source">Cell</infon><infon key="type">ref</infon><infon key="volume">77</infon><infon key="year">1994</infon><offset>25673</offset><text>Essential role for KH domains in RNA binding: impaired RNA binding by a mutation in the KH domain of FMR1 that causes fragile X syndrome</text></passage><passage><infon key="fpage">240</infon><infon key="lpage">249</infon><infon key="name_0">surname:Gustin;given-names:K.E.</infon><infon key="name_1">surname:Sarnow;given-names:P.</infon><infon key="pub-id_pmid">11226174</infon><infon key="source">Embo J.</infon><infon key="type">ref</infon><infon key="volume">20</infon><infon key="year">2001</infon><offset>25810</offset><text>Effects of poliovirus infection on nucleo-cytoplasmic trafficking and nuclear pore complex composition</text></passage><passage><infon key="fpage">269</infon><infon key="lpage">277</infon><infon key="name_0">surname:Matis;given-names:J.</infon><infon key="name_1">surname:Kudelova;given-names:M.</infon><infon key="pub-id_pmid">12083325</infon><infon key="source">Acta Virol.</infon><infon key="type">ref</infon><infon key="volume">45</infon><infon key="year">2001</infon><offset>25913</offset><text>Early shutoff of host protein synthesis in cells infected with herpes simplex viruses</text></passage><passage><infon key="fpage">280</infon><infon key="lpage">283</infon><infon key="name_0">surname:Salas;given-names:J.</infon><infon key="name_1">surname:Salas;given-names:M.L.</infon><infon key="name_2">surname:Vinuela;given-names:E.</infon><infon key="pub-id_pmid">3363868</infon><infon key="source">Virology</infon><infon key="type">ref</infon><infon key="volume">164</infon><infon key="year">1988</infon><offset>25999</offset><text>Effect of inhibitors of the host cell RNA polymerase II on African swine fever virus multiplication</text></passage><passage><infon key="fpage">2037</infon><infon key="lpage">2046</infon><infon key="name_0">surname:Alfonso;given-names:P.</infon><infon key="name_1">surname:Rivera;given-names:J.</infon><infon key="name_2">surname:Hernaez;given-names:B.</infon><infon key="name_3">surname:Alonso;given-names:C.</infon><infon key="name_4">surname:Escribano;given-names:J.M.</infon><infon key="pub-id_pmid">15221765</infon><infon key="source">Proteomics</infon><infon key="type">ref</infon><infon key="volume">4</infon><infon key="year">2004</infon><offset>26099</offset><text>Identification of cellular proteins modified in response to African swine fever virus infection by proteomics</text></passage><passage><infon key="fpage">1447</infon><infon key="lpage">1456</infon><infon key="name_0">surname:Rodriguez;given-names:J.M.</infon><infon key="name_1">surname:Salas;given-names:M.L.</infon><infon key="name_2">surname:Santaren;given-names:J.F.</infon><infon key="pub-id_pmid">11922604</infon><infon key="source">Proteomics</infon><infon key="type">ref</infon><infon key="volume">1</infon><infon key="year">2001</infon><offset>26209</offset><text>African swine fever virus-induced polypeptides in porcine alveolar macrophages and in Vero cells: two-dimensional gel analysis</text></passage><passage><infon key="type">fig_caption</infon><offset>26336</offset><text>Interaction of viral protein p30 with hnRNP-K in the GST fusion protein binding assay. (A) Viral protein p30, produced in the baculovirus system, was incubated with GST or GST-hnRNP-K beads (GST-K). Unrelated ASFV protein p54 was similarly used as negative control. After extensive washing and elution from beads, resulting protein complexes were electrophoresed and analyzed by WB with monoclonal anti-p30 or anti-p54 serum (see Section 2). (B) As described before, ASFV infected (BA71V) or mock infected (MI) protein cell extracts were incubated with GST-hnRNP-K (GST-K) beads and analyzed by WB with anti-p30 monoclonal antibody. In all cases C+ indicates p30 or p54 protein extracts used as positive Western blot controls.</text></passage><passage><infon key="type">fig_caption</infon><offset>27063</offset><text>Regions of p30 and hnRNP-K involved in the interaction. (A) Schematic representation of the diverse p30 truncations tested for interaction with full length hnRNP-K in the yeast two-hybrid assay. (B) Schematic representation of the diverse hnRNP-K truncations tested for interaction with complete p30 in the yeast two-hybrid assay. Structure with details of the different functional regions is shown [10]. NLS, nuclear localization signal; KH, K homology domains; KNS, bidirectional nuclear export signal. In all cases correspondent clones were analyzed for β-galactosidase activity indicating interaction (+) or no interaction (−) with respective partner tested.</text><annotation id="12"><infon key="type">ExperimentalMethod</infon><infon key="PSIMI">0018</infon><location offset="27119" length="274"/><text>(A) Schematic representation of the diverse p30 truncations tested for interaction with full length hnRNP-K in the yeast two-hybrid assay. (B) Schematic representation of the diverse hnRNP-K truncations tested for interaction with complete p30 in the yeast two-hybrid assay.</text></annotation></passage><passage><infon key="type">fig_caption</infon><offset>27729</offset><text>Colocalization of p30 and hnRNP-K in the nucleus of infected cells. Cells were infected with BA71V strain and analyzed at different times post infection by confocal immunofluorescence microscopy acquiring 0.1 μm optical sections from the Z-axis. A representative image of an infected cell at 8 hpi is shown (A). p30 was detected with a monoclonal anti-p30 followed by Alexa 647-conjugated goat anti-mouse antibody (red) and hnRNP-K with an anti-hnRNP-K specific serum followed by Alexa 488-conjugated goat anti-rabbit antibody (green). Discrete spots of colocalization of both proteins (orange) can be discerned in the cell nucleus. Bar, 10 μm. (B) Quantification of colocalization during infection. As described above, the nuclei of 30 infected cells were analyzed each time for hnRNP-K (black bars), p30 (white bars) and colocalization (grey bars) fluorescence emission. Data are expressed as percentages and normalized to total fluorescence due to hnRNP-K exclusively within the cell nucleus.</text><annotation id="13"><infon key="type">ExperimentalMethod</infon><infon key="PSIMI">0416</infon><location offset="27119" length="633"/><text>Colocalization of p30 and hnRNP-K in the nucleus of infected cells. Cells were infected with BA71V strain and analyzed at different times post infection by confocal immunofluorescence microscopy acquiring 0.1 μm optical sections from the Z-axis. A representative image of an infected cell at 8 hpi is shown (A). p30 was detected with a monoclonal anti-p30 followed by Alexa 647-conjugated goat anti-mouse antibody (red) and hnRNP-K with an anti-hnRNP-K specific serum followed by Alexa 488-conjugated goat anti-rabbit antibody (green). Discrete spots of colocalization of both proteins (orange) can be discerned in the cell nucleus.</text></annotation></passage><passage><infon key="type">fig_caption</infon><offset>28729</offset><text>ASFV infection induces changes in subcellular distribution of hnRNP-K. (A) Vero cells were either infected with BA71V (1 pfu/cell) or transfected with pCMV-p30 and analyzed by immunofluorescence microscopy at 8 hpi or 24 h post transfection, respectively. ASFV protein p30 was detected with a mouse anti-p30 monoclonal antibody and rhodamine red conjugated corresponding secondary antibody (red). hnRNP-K distribution in the cell nucleus was detected with a rabbit antiserum anti-hnRNP-K and Alexa Fluor 488 conjugated corresponding secondary antibody (green). Nuclei of cells were stained with Hoechst 3332. Accumulation of hnRNP-K in infected cells as spots which are coincident with the absence of nucleic acids staining can be appreciated in BA71V infected and pCMV-p30 transfected cells. Details of hnRNP-K accumulation are amplified from selected areas. (B) Comparison between uninfected and 12 hpi BA71V infected cell nuclei is shown in more detail. Arrows indicate the position of some of these structures in detail within the nucleus of an infected cell (bottom), but not in a non infected cell (top). VF indicates the perinuclear viral factory, identified by Hoechst staining in an infected cell. Bar, 16 μm.</text><annotation id="14"><infon key="type">ExperimentalMethod</infon><infon key="PSIMI">0416</infon><location offset="28729" length="792"/><text>ASFV infection induces changes in subcellular distribution of hnRNP-K. (A) Vero cells were either infected with BA71V (1 pfu/cell) or transfected with pCMV-p30 and analyzed by immunofluorescence microscopy at 8 hpi or 24 h post transfection, respectively. ASFV protein p30 was detected with a mouse anti-p30 monoclonal antibody and rhodamine red conjugated corresponding secondary antibody (red). hnRNP-K distribution in the cell nucleus was detected with a rabbit antiserum anti-hnRNP-K and Alexa Fluor 488 conjugated corresponding secondary antibody (green). Nuclei of cells were stained with Hoechst 3332. Accumulation of hnRNP-K in infected cells as spots which are coincident with the absence of nucleic acids staining can be appreciated in BA71V infected and pCMV-p30 transfected cells.</text></annotation></passage><passage><infon key="type">fig_caption</infon><offset>29951</offset><text>Analysis of hnRNP-K levels during ASFV infection by Western blot. Vero cells were infected with 5 pfu/cell of BA71V strain and analyzed by WB with specific antibodies at different times after infection. (A) p30 and hnRNP-K were detected in total protein cell extracts with specific antibodies (see Section 2). β-Tubulin was detected to ensure that same amount of total protein was loaded. (B) Levels of hnRNP-K were analyzed independently from nuclear and cytoplasmic protein infected cell extracts. One of three representative experiments is shown including the relative intensities of quantified hnRNP-K (rel. int.). β-Tubulin detection was included as quality control of the cellular fractionation. (C) Vero cells were infected with BA71V (0.5 pfu/cell) and analyzed at 12 hpi for incorporation of FU into nascent RNA after FU pulse (see Section 2) to evaluate transcriptional activity. Arrows indicate the position of infected cells identified by p30 detection with specific antibody. Note the increase of nuclear hnRNP-K staining of infected cells when compared to the non infected cells. Bar, 30 μm.</text></passage></document></collection>